Valuation: AstraZeneca PLC

Capitalization 231B 222B 209B 183B 328B 20,041B 364B 2,480B 926B 8,371B 865B 847B 34,965B P/E ratio 2025 *
22.9x
P/E ratio 2026 * 19.7x
Enterprise value 250B 240B 226B 198B 355B 21,687B 393B 2,684B 1,002B 9,058B 936B 917B 37,837B EV / Sales 2025 *
4.35x
EV / Sales 2026 * 3.98x
Free-Float
96.62%
Yield 2025 *
2.16%
Yield 2026 * 2.28%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.81%
1 week-0.83%
Current month+3.17%
1 month+8.43%
3 months+16.76%
6 months-10.31%
Current year+11.81%
More quotes
1 week
11 644.00
Extreme 11644
12 060.00
1 month
10 790.00
Extreme 10790
12 060.00
Current year
10 314.00
Extreme 10314
12 060.00
1 year
9 670.00
Extreme 9670
13 388.00
3 years
8 326.00
Extreme 8326
13 388.00
5 years
5 871.00
Extreme 5871
13 388.00
10 years
3 680.00
Extreme 3680
13 388.00
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 01/10/2012
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 57 01/01/2020
Director TitleAgeSince
Director/Board Member 69 06/04/1999
Director/Board Member 64 01/10/2012
Director/Board Member 64 27/04/2017
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-0.71%-0.83%+12.34%+27.91% 231B
+1.11%-0.71%+14.70%+262.46% 772B
+1.79%+1.69%+0.02%-2.02% 373B
+1.79%+2.01%-30.36%+83.59% 366B
+0.46%+2.20%+12.23%+35.50% 346B
-0.07%+1.03%+27.03%-13.20% 263B
+2.65%-0.12%-32.82%+12.67% 211B
+0.44%-1.24%+7.85%+22.53% 211B
+0.51%-0.27%+3.80%+32.91% 157B
+0.88%+1.53%-6.27%-45.59% 145B
Average +0.85%-0.47%+0.85%+41.68% 307.37B
Weighted average by Cap. +0.95%-0.46%+2.88%+82.52%
See all sector performances

Financials

2025 *2026 *
Net sales 57.32B 55.07B 51.86B 45.59B 81.53B 4,981B 90.37B 616B 230B 2,080B 215B 211B 8,690B 60.73B 58.35B 54.95B 48.3B 86.38B 5,278B 95.75B 653B 244B 2,204B 228B 223B 9,207B
Net income 10B 9.61B 9.05B 7.95B 14.22B 869B 15.76B 108B 40.12B 363B 37.48B 36.72B 1,516B 11.81B 11.35B 10.69B 9.39B 16.8B 1,027B 18.62B 127B 47.41B 429B 44.28B 43.39B 1,791B
Net Debt 18.94B 18.2B 17.14B 15.06B 26.94B 1,646B 29.86B 204B 76.01B 687B 70.99B 69.56B 2,871B 11.31B 10.87B 10.23B 9B 16.09B 983B 17.83B 122B 45.4B 411B 42.4B 41.54B 1,715B
More financial data * Estimated data
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Employees
89,900
Calendar
More about the company
Date Price Change Volume
20/02/25 11,704.00 p -0.71% 1,261,683
18/02/25 11,788.00 p +0.63% 1,256,095
17/02/25 11,714.00 p +0.05% 719,403
14/02/25 11,708.00 p -2.14% 3,001,390
13/02/25 11,964.00 p +1.37% 4,659,511

Delayed Quote London S.E., 20 February 2025 at 03:35 am AEDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
148.72USD
Average target price
177.32USD
Spread / Average Target
+19.23%
Consensus

Quarterly revenue - Rate of surprise